These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 9579076)
1. Carbapenems as inhibitors of OXA-13, a novel, integron-encoded beta-lactamase in Pseudomonas aeruginosa. Mugnier P; Podglajen I; Goldstein FW; Collatz E Microbiology (Reading); 1998 Apr; 144 ( Pt 4)():1021-1031. PubMed ID: 9579076 [TBL] [Abstract][Full Text] [Related]
2. OXA-15, an extended-spectrum variant of OXA-2 beta-lactamase, isolated from a Pseudomonas aeruginosa strain. Danel F; Hall LM; Gur D; Livermore DM Antimicrob Agents Chemother; 1997 Apr; 41(4):785-90. PubMed ID: 9087490 [TBL] [Abstract][Full Text] [Related]
3. OXA-11, an extended-spectrum variant of OXA-10 (PSE-2) beta-lactamase from Pseudomonas aeruginosa. Hall LM; Livermore DM; Gur D; Akova M; Akalin HE Antimicrob Agents Chemother; 1993 Aug; 37(8):1637-44. PubMed ID: 8215276 [TBL] [Abstract][Full Text] [Related]
4. OXA-18, a class D clavulanic acid-inhibited extended-spectrum beta-lactamase from Pseudomonas aeruginosa. Philippon LN; Naas T; Bouthors AT; Barakett V; Nordmann P Antimicrob Agents Chemother; 1997 Oct; 41(10):2188-95. PubMed ID: 9333046 [TBL] [Abstract][Full Text] [Related]
5. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea. Cho HH; Kwon GC; Kim S; Koo SH J Microbiol Biotechnol; 2015 Jul; 25(7):1154-62. PubMed ID: 25907063 [TBL] [Abstract][Full Text] [Related]
6. OXA-46, a new class D beta-lactamase of narrow substrate specificity encoded by a blaVIM-1-containing integron from a Pseudomonas aeruginosa clinical isolate. Giuliani F; Docquier JD; Riccio ML; Pagani L; Rossolini GM Antimicrob Agents Chemother; 2005 May; 49(5):1973-80. PubMed ID: 15855521 [TBL] [Abstract][Full Text] [Related]
7. OXA-35 is an OXA-10-related beta-lactamase from Pseudomonas aeruginosa. Aubert D; Poirel L; Ali AB; Goldstein FW; Nordmann P J Antimicrob Chemother; 2001 Nov; 48(5):717-21. PubMed ID: 11679562 [TBL] [Abstract][Full Text] [Related]
8. Imipenem and cephem resistant Pseudomonas aeruginosa carrying plasmids coding for class B beta-lactamase. Minami S; Akama M; Araki H; Watanabe Y; Narita H; Iyobe S; Mitsuhashi S J Antimicrob Chemother; 1996 Mar; 37(3):433-44. PubMed ID: 9182100 [TBL] [Abstract][Full Text] [Related]
9. Comparative activity of meropenem against Pseudomonas aeruginosa strains with well-characterized resistance mechanisms. Livermore DM; Yang YJ J Antimicrob Chemother; 1989 Sep; 24 Suppl A():149-59. PubMed ID: 2553657 [TBL] [Abstract][Full Text] [Related]
10. Role of cephalosporinase in carbapenem resistance of clinical isolates of Pseudomonas aeruginosa. Zhou XY; Kitzis MD; Gutmann L Antimicrob Agents Chemother; 1993 Jun; 37(6):1387-9. PubMed ID: 8328794 [TBL] [Abstract][Full Text] [Related]
11. A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD. Maniati M; Ikonomidis A; Mantzana P; Daponte A; Maniatis AN; Pournaras S J Antimicrob Chemother; 2007 Jul; 60(1):132-5. PubMed ID: 17483142 [TBL] [Abstract][Full Text] [Related]
12. OXA-28, an extended-spectrum variant of OXA-10 beta-lactamase from Pseudomonas aeruginosa and its plasmid- and integron-located gene. Poirel L; Girlich D; Naas T; Nordmann P Antimicrob Agents Chemother; 2001 Feb; 45(2):447-53. PubMed ID: 11158739 [TBL] [Abstract][Full Text] [Related]
13. OXA-198, an acquired carbapenem-hydrolyzing class D beta-lactamase from Pseudomonas aeruginosa. El Garch F; Bogaerts P; Bebrone C; Galleni M; Glupczynski Y Antimicrob Agents Chemother; 2011 Oct; 55(10):4828-33. PubMed ID: 21788473 [TBL] [Abstract][Full Text] [Related]
14. Comparative activity of beta-lactam agents (carbapenem excepted) against Pseudomonas aeruginosa strains with CARB or OXA beta-lactamases. Bert F; Branger C; Lambert-Zechovsky N Chemotherapy; 2004 Apr; 50(1):31-4. PubMed ID: 15084803 [TBL] [Abstract][Full Text] [Related]
15. Novel OXA-10-derived extended-spectrum beta-lactamases selected in vivo or in vitro. Mugnier P; Casin I; Bouthors AT; Collatz E Antimicrob Agents Chemother; 1998 Dec; 42(12):3113-6. PubMed ID: 9835500 [TBL] [Abstract][Full Text] [Related]
16. Description of IMP-31, a novel metallo-β-lactamase found in an ST235 Pseudomonas aeruginosa strain in Western Germany. Pfennigwerth N; Geis G; Gatermann SG; Kaase M J Antimicrob Chemother; 2015 Jul; 70(7):1973-80. PubMed ID: 25835992 [TBL] [Abstract][Full Text] [Related]
17. Characterization of Class 1 integrons from Pseudomonas aeruginosa that contain the bla(VIM-2) carbapenem-hydrolyzing beta-lactamase gene and of two novel aminoglycoside resistance gene cassettes. Poirel L; Lambert T; Türkoglü S; Ronco E; Gaillard J; Nordmann P Antimicrob Agents Chemother; 2001 Feb; 45(2):546-52. PubMed ID: 11158753 [TBL] [Abstract][Full Text] [Related]
19. WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D β-lactamases. Mushtaq S; Vickers A; Woodford N; Livermore DM J Antimicrob Chemother; 2017 Jun; 72(6):1688-1695. PubMed ID: 28333319 [TBL] [Abstract][Full Text] [Related]
20. Lack of additive effect between mechanisms of resistance to carbapenems and other beta-lactam agents in Pseudomonas aeruginosa. Dib C; Trias J; Jarlier V Eur J Clin Microbiol Infect Dis; 1995 Nov; 14(11):979-86. PubMed ID: 8654449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]